HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Patrick E. Parrino Robert C. King Curtis G. Tribble Irving L. Kron Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parrino, P. E. Articles by Kron, I. L. Search for Related Content PubMed PubMed Citation Articles by Parrino, P. E. Articles by Kron, I. L.

Ann Thorac Surg 1998;66:733-739
© 1998 The Society of Thoracic Surgeons

---

Original articles: Cardiovascular

Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow

^a Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA

Address reprint requests to Dr Kron, Department of Surgery, Box 310, University of Virginia Health Sciences Center, Charlottesville, VA 22908
e-mail: (ikron{at}virginia.edu)

Presented at the Forty-fourth Annual Meeting of the Southern Thoracic Surgical Association, Naples, FL, Nov 6–8, 1997.

Background. The role of nitric oxide synthase in myocardial ischemia–reperfusion injury is complex. Our hypothesis was that inducible nitric oxide synthase has a role in the regulation of coronary flow after ischemia.

Methods. Four groups of isolated blood-perfused rabbit hearts underwent sequential periods of perfusion, ischemia, and reperfusion (20, 30, and 20 minutes). Two groups underwent 40 minutes of perfusion. Ischemic groups received saline vehicle, N-nitro-L-arginine methyl ester (L-NAME) or the highly specific inducible nitric oxide synthase inhibitor 1400W in low or high doses during reperfusion. Two nonischemic groups were treated with saline vehicle or 1400W during the last 20 minutes of perfusion. Left ventricular developed pressure and coronary flow were measured after each perfusion period. Ventricular levels of myeloperoxidase and cyclic guanosine monophosphate were measured at the end of the second perfusion period.

Results. Coronary flow was significantly increased in both 1400W groups versus L-NAME (p < 0.001) and in high-dose 1400W versus control (p < 0.001). Coronary flow was not significantly different between the nonischemic groups. Left ventricular developed pressure was not significantly different among the ischemic groups or between the two nonischemic groups. There were no differences in cyclic guanosine monophosphate levels in any of the ischemic hearts. Myeloperoxidase levels were significantly elevated in L-NAME versus high-dose 1400W, nonischemic 1400W, and nonischemic saline groups (p < 0.02).

Conclusions. Highly selective inhibition of inducible nitric oxide synthase results in increased coronary flow after ischemia but not after continuous perfusion. This occurs with decreased neutrophil accumulation and a trend toward increased contractility without elevation of cyclic guanosine monophosphate levels.

This article has been cited by other articles:

				D. J. Vaughan, T. V. Brogan, M. E. Kerr, S. Deem, D. L. Luchtel, and E. R. Swenson Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungs Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L834 - L843. [Abstract] [Full Text] [PDF]

				L. Zhang, C. G. Looney, W.-N. Qi, L.-E. Chen, A. V. Seaber, J. S. Stamler, and J. R. Urbaniak Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase J Appl Physiol, April 1, 2003; 94(4): 1473 - 1478. [Abstract] [Full Text] [PDF]

				S. Kanno, P. C. Lee, Y. Zhang, C. Ho, B. P. Griffith, L. L. Shears II, and T. R. Billiar Attenuation of Myocardial Ischemia/Reperfusion Injury by Superinduction of Inducible Nitric Oxide Synthase Circulation, June 13, 2000; 101(23): 2742 - 2748. [Abstract] [Full Text] [PDF]

				G. Cotter, E. Kaluski, A. Blatt, O. Milovanov, Y. Moshkovitz, R. Zaidenstein, A. Salah, D. Alon, Y. Michovitz, M. Metzger, et al. L-NMMA (a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock Circulation, March 28, 2000; 101(12): 1358 - 1361. [Abstract] [Full Text] [PDF]

				Z. Yang, B. Zingarelli, and C. Szabo Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury Circulation, March 7, 2000; 101(9): 1019 - 1026. [Abstract] [Full Text] [PDF]